4th Feb 2008 15:08
GlaxoSmithKline PLC04 February 2008 Further to an announcement made on 7 December 2007 relating to the appointmentsof Andrew Witty and Christopher Viehbacher as Executive Directors ofGlaxoSmithKline plc with effect as of 31 January 2008, the following details areprovided in accordance with the requirements of the Financial ServicesAuthority's Listing Rules on their appointment to the Board of GlaxoSmithKlineplc. Neither Mr Witty nor Mr Viehbacher has been a director of a publicly quotedcompany during the past five years. Neither Mr Witty nor Mr Viehbacher have any details to disclose in respect of LR9.6.13R (2) to (6) of the Financial Services Authority's Listing Rules. S M Bicknell Company Secretary 4 February 2008 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline